» Articles » PMID: 20160146

Chaperone-mediated Autophagy

Overview
Specialty Pulmonary Medicine
Date 2010 Feb 18
PMID 20160146
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Continuous renewal of intracellular components is required to preserve cellular functionality. In fact, failure to timely turnover proteins and organelles leads often to cell death and disease. Different pathways contribute to the degradation of intracellular components in lysosomes or autophagy. In this review, we focus on chaperone-mediated autophagy (CMA), a selective form of autophagy that modulates the turnover of a specific pool of soluble cytosolic proteins. Selectivity in CMA is conferred by the presence of a targeting motif in the cytosolic substrates that, upon recognition by a cytosolic chaperone, determines delivery to the lysosomal surface. Substrate proteins undergo unfolding and translocation across the lysosomal membrane before reaching the lumen, where they are rapidly degraded. Better molecular characterization of the different components of this pathway in recent years, along with the development of transgenic models with modified CMA activity and the identification of CMA dysfunction in different severe human pathologies and in aging, are all behind the recent regained interest in this catabolic pathway.

Citing Articles

Targeting regulated cell death pathways in cancers for effective treatment: a comprehensive review.

Saxena R, Welsh C, He Y Front Cell Dev Biol. 2024; 12:1462339.

PMID: 39620145 PMC: 11604647. DOI: 10.3389/fcell.2024.1462339.


The role of autophagy in brain health and disease: Insights into exosome and autophagy interactions.

Wang H, Lv C, Feng L, Guo J, Zhao S, Jiang P Heliyon. 2024; 10(21):e38959.

PMID: 39524893 PMC: 11546156. DOI: 10.1016/j.heliyon.2024.e38959.


Targeted protein degradation: advances in drug discovery and clinical practice.

Zhong G, Chang X, Xie W, Zhou X Signal Transduct Target Ther. 2024; 9(1):308.

PMID: 39500878 PMC: 11539257. DOI: 10.1038/s41392-024-02004-x.


Evidence for the potential role of m6A modification in regulating autophagy in models of amyotrophic lateral sclerosis.

An D, Han J, Fang P, Bu Y, Ji G, Liu M Cytojournal. 2024; 21:33.

PMID: 39411168 PMC: 11474754. DOI: 10.25259/Cytojournal_101_2024.


Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways.

Koszla O, Solek P Cell Commun Signal. 2024; 22(1):421.

PMID: 39215343 PMC: 11365204. DOI: 10.1186/s12964-024-01791-8.


References
1.
Ding Q, Dimayuga E, Martin S, Bruce-Keller A, Nukala V, Cuervo A . Characterization of chronic low-level proteasome inhibition on neural homeostasis. J Neurochem. 2003; 86(2):489-97. DOI: 10.1046/j.1471-4159.2003.01885.x. View

2.
Cuervo A, Dice J . Regulation of lamp2a levels in the lysosomal membrane. Traffic. 2001; 1(7):570-83. DOI: 10.1034/j.1600-0854.2000.010707.x. View

3.
Ravikumar B, Futter M, Jahreiss L, Korolchuk V, Lichtenberg M, Luo S . Mammalian macroautophagy at a glance. J Cell Sci. 2009; 122(Pt 11):1707-11. PMC: 2684830. DOI: 10.1242/jcs.031773. View

4.
Agarraberes F, Dice J . A molecular chaperone complex at the lysosomal membrane is required for protein translocation. J Cell Sci. 2001; 114(Pt 13):2491-9. DOI: 10.1242/jcs.114.13.2491. View

5.
Cuervo A, Knecht E, Terlecky S, Dice J . Activation of a selective pathway of lysosomal proteolysis in rat liver by prolonged starvation. Am J Physiol. 1995; 269(5 Pt 1):C1200-8. DOI: 10.1152/ajpcell.1995.269.5.C1200. View